Understanding variation in measles-mumps-rubella immunization coverage--a population-based study

James A Wright1, Clare Polack

  • 1Department of Geography, University of Southampton, Highfield, Southampton SO17 1BJ, UK. j.a.wright@soton.ac.uk

Abstract

Insights

Measles-Mumps-Rubella (MMR) vaccine coverage has declined across England, particularly in urban areas. Deprivation and population density correlate with lower MMR uptake, highlighting a need for targeted public health interventions.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • Measles-Mumps-Rubella (MMR) vaccine coverage has decreased in the UK due to concerns linking the vaccine to autism and Crohn's disease.
  • Assessing geographical variations and population-level factors influencing MMR uptake is crucial.

Purpose of the Study:

  • To evaluate geographical trends in MMR vaccine coverage in England.
  • To identify factors associated with MMR immunization uptake at a population level.

Main Methods:

  • An ecological study utilizing routine immunization data from 1993-2004 for 95 District Health Authorities in England.
  • Analysis of relationships between MMR uptake and socioeconomic deprivation, ethnicity, education, population density, rurality, and social class.

Main Results:

  • MMR coverage has significantly declined in most English regions since 2000.
  • Higher population density and deprivation levels were strongly associated with lower MMR vaccine uptake.
  • Coverage decline was linked to the proportion of the educated population and was more pronounced in densely populated areas.

Conclusions:

  • Declining MMR coverage is widespread across England, with the lowest rates in deprived urban areas.
  • Public health efforts should prioritize inner-city regions and address vaccine safety concerns among educated populations.
  • Understanding geographical disparities in MMR uptake is essential for effective public health strategies.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.